The “last mile problem” and achieving widespread adoption of innovations in health care delivery.
UHF's experts help make sense of our changing health care system.
UHF is a hub of activity—policy research, data analysis, stakeholder convenings, grantmaking, and more. See our newsletters for updates on the work most relevant to you.
UHF's Tribute to Excellence in Health Care recognizes quality improvement champions across the New York metropolitan area.
We are now accepting nominations for the 2020 Distinguished Community Service Award, to be presented at the UHF Gala in October. The award recognizes outstanding voluntary leadership in health and health care in the metropolitan New York area.
What we're accomplishing with your donations.
This issue brief analyzes recent growth in spending for prescription drugs by health plans in New York State-and the implications of that growth for policymakers and consumers. Prescription drug cost increases are exerting considerable pressure on the state budget, public and private health plans, and enrollees, and will likely continue to do so.
The brief presents per member per month (PMPM) data over time for health plans in two markets: Medicaid Managed Care and small group commercial. Among commercial plans, PMPM drug spending rose an average of 62 percent between 2011 and 2016. Among Medicaid Managed Care plans, which report spending for certain higher cost drugs in a separate category, PMPM drug spending rose an average of 21 percent between 2013 and 2015.
Restraining the rate of growth in these costs will involve a difficult balancing act, and strong collaboration among all parties-particularly amid federal calls for significant cuts in state Medicaid funding, and reductions in premium and cost-sharing subsidies.
Read the related press release.